Sygnature Discovery at BioJapan 2017 – Participating in UK Department of International Trade Mission
11th October 2017 – Yokohama, Japan – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is participating in BioJapan 2017 from 11th – 13th October 2017 in Yokohama. Sygnature is part of a UK Department of International Trade (UK DIT) Mission and is located on the UK Pavilion (Booth No. […]
9th October 2017 – London and Nottingham, UK – Phoenix Equity Partners (“Phoenix”), a leading UK middle-market private equity firm, today announces an investment in Sygnature Discovery Limited (“Sygnature” or “the Company”) alongside the current management team, led by Founder and CEO Dr Simon Hirst. The deal will provide Sygnature with additional investment to support […]
6th October 2017, Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has been named as the winner of the Best Contract Research Organisation award at the OBN Awards 2017. The OBN Awards 2017, now in their 9th year, celebrate innovation and outstanding achievement across the UK […]
View All News
Meet Sygnature at the following Conferences throughout 2015:
Biotech Showcase/JP Morgan
9-11th January 2017
San Francisco USA
RSC OrgSyn 50
27-28 February 2017
Proventa Medicinal Chemistry Strategy
14th March 2017
View All Conferences
View All Media
KINASE INHIBITORS, FRICKEL, Fritz-Frieder
KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).
PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne
PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).
KINASE INHIBITORS, FYFE, Matthew Colin Thor
KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).
View All Publications
Director of Marketing